Injection site reactions, such as bleeding or pain ... can recommend different treatment options depending on the type of reaction. The typical starting dose of Zepbound is 2.5 milligrams ...

Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea in obese adults ...

The U.S. Food and Drug Administration has approved Zepbound (tirzepatide) as the first drug treatment for adults ... as well as injection site reactions and fatigue. More serious concerns ...

The FDA says side effects for Zepbound include nausea, diarrhea, vomiting, constipation, stomach pain, reactions at the injection site ... combining another treatment with Zepbound may be ideal ...

An injection ... as Zepbound for weight loss and Mounjaro as a diabetes treatment. Zepbound's side effects can include nausea, diarrhea, vomiting, constipation, stomach discomfort and pain.

Medicare drug plans can now cover Eli Lilly & Co.’s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that’s expected to prove a big boost for the drug company.

(RTTNews) - The U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate ... discomfort and pain, injection site reactions, fatigue, hypersensitivity ...

The FDA statement details the side effects of Zepbound, which include nausea, vomiting, belching, acid reflux, stomach pain, diarrhea, constipation, injection site reactions, tiredness ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved ...

The FDA has approved Zepbound, a popular weight loss drug, for the treatment of moderate-to-severe ... FILE - Zepbound injection pen (Photographer: Shelby Knowles/Bloomberg via Getty Images ...